Background: Diabetic retinopathy (DR) is a major cause of blindness globally. Sodium Glucose Cotransporter-2 (SGLT2) inhibitors have been demonstrated to exert cardiorenal protection in patients with diabetes. However. their potential beneficial effect on DR is less well studied. https://www.foldlyers.shop/product-category/usb-3-1-type-c-gen-2-to-usb-type-c/